We are live on
!
Find out more
SA
Sicart Associates Portfolio holdings
AUM
$389M
1-Year Est. Return
42.46%
This Fund
S&P 500
This Quarter
Est. Return
+4.46%
1 Year Est. Return
+42.46%
3 Year Est. Return
+89.06%
5 Year Est. Return
+118.65%
10 Year Est. Return
–
AUM
$145M
AUM Growth
–
Cap. Flow
+$140M
Cap. Flow
% of AUM
96.74%
Top 10 Holdings %
Top 10 Hldgs %
37.51%
Holding
100
New
100
Increased
–
Reduced
–
Closed
–
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Ionis Pharmaceuticals
IONS
|
+$11.1M |
| 2 |
SPDR Gold Trust
GLD
|
+$6.86M |
| 3 |
PXD
Pioneer Natural Resource Co.
PXD
|
+$5.37M |
| 4 |
POT
Potash Corp Of Saskatchewan
POT
|
+$4.54M |
| 5 |
PTC Therapeutics
PTCT
|
+$4.52M |
Top Sells
No sells this quarter
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Healthcare | 24.27% |
| 2 | Technology | 17.32% |
| 3 | Energy | 16.51% |
| 4 | Industrials | 11.97% |
| 5 | Materials | 4.77% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
76
Alkermes
ALKS
$8.22B
| $445K | 0.31% |
+8,000
| New | +$428K |
|
77
Target
TGT
$65.6B
| $444K | 0.31% |
+6,150
| New | +$445K |
|
78
Sonoco
SON
$5.57B
| $422K | 0.29% |
+8,000
| New | +$417K |
|
|
NBL
79
DELISTED
Noble Energy, Inc.
NBL
| $381K | 0.26% |
+10,000
| New | +$372K |
|
|
SVC
80
Service Properties Trust
SVC
$1.04B
| $375K | 0.26% |
+2,360
| New | +$342K |
|
|
XL
81
DELISTED
XL Group Ltd.
XL
| $373K | 0.26% |
+10,000
| New | +$359K |
|
82
Williams-Sonoma
WSM
$26.9B
| $353K | 0.24% |
+14,580
| New | +$372K |
|
|
B
83
Barrick Mining
B
$61.5B
| $332K | 0.23% |
+20,765
| New | +$329K |
|
84
MetLife
MET
$61.9B
| $323K | 0.22% |
+6,732
| New | +$309K |
|
85
Cameco
CCJ
$37.6B
| $314K | 0.22% |
+30,000
| New | +$271K |
|
|
SGMO
86
DELISTED
SANGAMO THERAPEUTICS INC
SGMO
| $311K | 0.21% |
+101,950
| New | +$371K |
|
87
Adient
ADNT
$1.65B
| $306K | 0.21% |
+5,225
| New | +$276K |
|
88
Adobe
ADBE
$99.5B
| $278K | 0.19% |
+2,700
| New | +$286K |
|
89
BGC Group
BGC
$5.52B
| $272K | 0.19% |
+41,363
| New | +$251K |
|
|
DBD
90
DELISTED
Diebold Nixdorf Incorporated
DBD
| $272K | 0.19% |
+10,800
| New | +$255K |
|
91
Howmet Aerospace
HWM
$113B
| $260K | 0.18% |
+18,298
| New | +$275K |
|
92
ProShares UltraShort QQQ
QID
$282M
| $239K | 0.17% |
+125
| New | +$244K |
|
|
EGN
93
DELISTED
Energen
EGN
| $231K | 0.16% |
+4,000
| New | +$228K |
|
94
Abbott
ABT
$183B
| $229K | 0.16% |
+5,954
| New | +$236K |
|
95
Pitney Bowes
PBI
$2.37B
| $228K | 0.16% |
+15,000
| New | +$239K |
|
96
ProShares Short QQQ
PSQ
$824M
| $227K | 0.16% |
+960
| New | +$229K |
|
97
BlackRock Corporate High Yield Fund
HYT
$1.36B
| $138K | 0.1% |
+12,750
| New | +$134K |
|
|
GST
98
DELISTED
Gastar Exploration Inc.
GST
| $36K | 0.02% |
+23,000
| New | +$27.8K |
|
Similar funds
AIM
WCM
HP
P8IP
PFPGI
PG
S
LHC
Sicart Associates's Q4 2016 Portfolio in Review
Q4 2016 is the first quarter with a 13F filing on record for Sicart Associates, which disclosed 100 positions worth $145M. Its ten largest holdings account for 38% of the portfolio.
Its largest position is Ionis Pharmaceuticals: 280,315 shares worth $13.4M.
By sector, the portfolio is most concentrated in Healthcare at 24% of assets, followed by Technology and Energy.
- Sicart Associates's largest Q4 2016 buy was Ionis Pharmaceuticals: 280,315 shares worth $13.4M.
- Sicart Associates's ten largest holdings make up 38% of its $145M portfolio in Q4 2016.
- Sicart Associates disclosed 100 positions in Q4 2016, its first 13F filing on record.
Based on Sicart Associates's 13F filing for Q4 2016, filed 7 Feb 2017.